| scholarly article | Q13442814 |
| P50 | author | Marc D. Normandin | Q38361604 |
| P2093 | author name string | Y Huang | |
| D Piomelli | |||
| S Henry | |||
| S F Lin | |||
| A Neumeister | |||
| M Q Zheng | |||
| R E Carson | |||
| M N Potenza | |||
| C R Bailey | |||
| R H Pietrzak | |||
| S Corsi-Travali | |||
| J Ropchan | |||
| A Gujarro-Anton | |||
| S Najafzadeh | |||
| P2860 | cites work | Cannabis and psychiatric disorders: it is not only addiction | Q22242611 |
| Cannabinoid receptor localization in brain | Q24558751 | ||
| Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 | ||
| Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: A systematic review and meta-analysis | Q27004411 | ||
| Emotion circuits in the brain | Q27860733 | ||
| The assessment of anxiety states by rating | Q29614719 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire | Q29615435 | ||
| Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats | Q30437947 | ||
| Memory modulation | Q30460201 | ||
| Exposure to the tsunami disaster, PTSD symptoms and increased substance use - an Internet based survey of male and female residents of Switzerland | Q33325684 | ||
| Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure | Q34104954 | ||
| Estrogenic regulation of limbic cannabinoid receptor binding | Q34105250 | ||
| Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers | Q34199610 | ||
| The development of a Clinician-Administered PTSD Scale | Q34308213 | ||
| Fear conditioning induces associative long-term potentiation in the amygdala | Q34449814 | ||
| Consensus nomenclature for in vivo imaging of reversibly binding radioligands | Q34630958 | ||
| Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence | Q34639648 | ||
| Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment | Q34798544 | ||
| The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). | Q34948227 | ||
| The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding | Q35630395 | ||
| Molecular mechanisms underlying emotional learning and memory in the lateral amygdala | Q35902483 | ||
| The endocannabinoid system: a drug discovery perspective. | Q36207547 | ||
| Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions | Q36323828 | ||
| Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity | Q36546326 | ||
| Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents | Q36775155 | ||
| Adrenal stress hormones, amygdala activation, and memory for emotionally arousing experiences | Q37013604 | ||
| Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory | Q37140016 | ||
| Endocannabinoids: The silent partner of glucocorticoids in the synapse | Q37140089 | ||
| An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics. | Q37273418 | ||
| PTSD contributes to teen and young adult cannabis use disorders | Q37442546 | ||
| Sex-dependent alterations in response to maternal deprivation in rats. | Q37530019 | ||
| Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. | Q37808580 | ||
| Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. | Q37926645 | ||
| Gender differences in susceptibility to posttraumatic stress disorder | Q40761668 | ||
| Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain | Q42451047 | ||
| Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement | Q42504533 | ||
| Strategies to improve neuroreceptor parameter estimation by linear regression analysis | Q42526696 | ||
| The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. | Q42686860 | ||
| Depression-like phenotype following chronic CB1 receptor antagonism | Q43104152 | ||
| The endogenous cannabinoid system controls extinction of aversive memories | Q44085607 | ||
| Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels. | Q44783539 | ||
| [123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients. | Q44863968 | ||
| CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents | Q44977076 | ||
| Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress | Q45138851 | ||
| Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | Q45173372 | ||
| Norepinephrine in the brain is associated with aversion to financial loss | Q45898216 | ||
| Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. | Q46590501 | ||
| Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. | Q46825379 | ||
| Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil | Q48097281 | ||
| Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress | Q48163197 | ||
| Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner | Q48272311 | ||
| Large receptor reserve for cannabinoid actions in the central nervous system. | Q48299894 | ||
| 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors | Q48406514 | ||
| 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors | Q48966515 | ||
| Autism recurrence in half siblings: strong support for genetic mechanisms of transmission in ASD | Q50308298 | ||
| The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD | Q50771289 | ||
| Column-switching HPLC for the analysis of plasma in PET imaging studies | Q51373704 | ||
| An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. | Q52271086 | ||
| Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. | Q53447148 | ||
| The development of a Clinician-Administered PTSD Scale | Q57482641 | ||
| Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire | Q73974041 | ||
| Post-traumatic stress disorder | Q77471746 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| positron emission tomography | Q208376 | ||
| post-traumatic stress disorder | Q202387 | ||
| cannabinoid receptor | Q421237 | ||
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 1034-1040 | |
| P577 | publication date | 2013-05-14 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study | |
| P478 | volume | 18 |
| Q90529302 | 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics |
| Q28297569 | 50 years of hurdles and hope in anxiolytic drug discovery |
| Q92898097 | A Clinician's Guide to PTSD Biomarkers and Their Potential Future Use |
| Q57023260 | A novel rat model of comorbid PTSD and addiction reveals intersections between stress susceptibility and enhanced cocaine seeking with a role for mGlu5 receptors |
| Q47120434 | Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors |
| Q27026443 | Amygdala FAAH and anandamide: mediating protection and recovery from stress |
| Q30375098 | An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials |
| Q44347124 | Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology |
| Q36254356 | Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB. |
| Q92649379 | Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation |
| Q64083720 | Cannabinoid Regulation of Fear and Anxiety: an Update |
| Q37649879 | Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans |
| Q34393055 | Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors |
| Q48191152 | Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. |
| Q30400006 | Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing |
| Q41725033 | Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males |
| Q91775177 | Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome |
| Q93167527 | Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice |
| Q38598509 | Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes |
| Q34535259 | Clinical applications of hallucinogens: A review |
| Q33772366 | Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling |
| Q30366747 | Developmental regulation of fear learning and anxiety behavior by endocannabinoids. |
| Q28082087 | Diagnostic Biomarkers for Posttraumatic Stress Disorder: Promising Horizons from Translational Neuroscience Research |
| Q59131907 | Diminished positive affect and traumatic stress: A biobehavioral review and commentary on trauma affective neuroscience |
| Q94563364 | Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice |
| Q30366949 | Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed |
| Q36417706 | Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease |
| Q61456313 | Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety |
| Q50537412 | Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex. |
| Q96294260 | Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C]CURB positron emission tomography study |
| Q28083141 | Emerging drugs for the treatment of anxiety |
| Q36690681 | Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats |
| Q94569525 | Endocannabinoid System Components as Potential Biomarkers in Psychiatry |
| Q57166606 | Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies |
| Q39644581 | Endocannabinoid signaling within the basolateral amygdala integrates multiple stress hormone effects on memory consolidation |
| Q35789082 | Endocannabinoids and Mental Disorders |
| Q42635177 | Erratum: Targeting the endocannabinoid system to treat haunting traumatic memories |
| Q59791745 | Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression |
| Q38809372 | FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence |
| Q50675640 | Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders |
| Q36409621 | Finding translation in stress research |
| Q27310769 | Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids |
| Q37088174 | Genetics as a molecular window into recovery, its treatment, and stress responses after stroke |
| Q64240022 | Glucocorticoid-induced enhancement of extinction-from animal models to clinical trials |
| Q27321190 | Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences |
| Q36019618 | Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder. |
| Q39459073 | Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder |
| Q30392035 | Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention |
| Q33736941 | Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders |
| Q38378939 | Investigational drugs under development for the treatment of PTSD. |
| Q39388243 | Is cannabis treatment for anxiety, mood, and related disorders ready for prime time? |
| Q37349180 | Linking plasma cortisol levels to phenotypic heterogeneity of posttraumatic stress symptomatology |
| Q98733457 | Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis |
| Q99350059 | Low brain endocannabinoids associated with persistent non-goal directed nighttime hyperactivity after traumatic brain injury in mice |
| Q38428844 | Maintenance of aversive memories shown by fear extinction-impaired phenotypes is associated with increased activity in the amygdaloid-prefrontal circuit |
| Q91574934 | Marijuana Use in Pregnancy and While Breastfeeding |
| Q52674788 | Mechanisms Underlying Sex Differences in Cannabis Use. |
| Q34570676 | Medical marijuana: more questions than answers |
| Q35200833 | Metabolite profiling in posttraumatic stress disorder |
| Q26767636 | Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review |
| Q36236067 | Molecular Neuroimaging in Posttraumatic Stress Disorder. |
| Q22299116 | Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders |
| Q36366731 | Neurobiological Interactions Between Stress and the Endocannabinoid System. |
| Q88968268 | Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies |
| Q37657596 | Neuroimaging in Alcohol and Drug Dependence |
| Q57048326 | New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders |
| Q34445824 | Organ-specific physiological responses to acute physical exercise and long-term training in humans |
| Q48096370 | Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study |
| Q39249530 | P2X3 receptor-mediated visceral hyperalgesia and neuronal sensitization following exposure to PTSD-like stress in the dorsal root ganglia of rats |
| Q37116261 | PKCγ Receptor Mediates Visceral Nociception and Hyperalgesia following Exposure to PTSD-Like Stress in the Spinal Cord of Rats |
| Q28070159 | PTSD: from neurobiology to pharmacological treatments |
| Q47303206 | Pharmacokinetics of the cannabinoid receptor ligand [18 F]MK-9470 in the rat brain - Evaluation of models using microPET. |
| Q27006437 | Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders |
| Q52643582 | Plasma anandamide concentrations are lower in children with autism spectrum disorder |
| Q59785696 | Post-traumatic stress disorder |
| Q58213889 | Posttraumatic Stress Disorder: An Integrated Overview of the Neurobiological Rationale for Pharmacology |
| Q48099646 | Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder |
| Q47410020 | Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine |
| Q36945634 | Reduced Brain Cannabinoid Receptor Availability in Schizophrenia |
| Q37409877 | Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks |
| Q54490551 | Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. |
| Q47577052 | Sex differences in hippocampal response to endocannabinoids after exposure to severe stress |
| Q48234381 | Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective |
| Q41791000 | Short overview on metabolomic approach and redox changes in psychiatric disorders. |
| Q38680816 | Stress and Memory: A Selective Review on Recent Developments in the Understanding of Stress Hormone Effects on Memory and Their Clinical Relevance. |
| Q39018484 | Stress, glucocorticoids and memory: implications for treating fear-related disorders |
| Q64263267 | The Divergent Effects of CDPPB and Cannabidiol on Fear Extinction and Anxiety in a Predator Scent Stress Model of PTSD in Rats |
| Q33900638 | The Impact of Stress Hormones on Post-traumatic Stress Disorders Symptoms and Memory in Cardiac Surgery Patients. |
| Q58707392 | The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity |
| Q37083923 | The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) |
| Q39257178 | The endocannabinoid system as a target for novel anxiolytic drugs |
| Q50015173 | The impact of PTSD clusters on cannabis use in a racially diverse trauma-exposed sample: An analysis from ecological momentary assessment. |
| Q36664783 | The rs1049353 polymorphism in the CNR1 gene interacts with childhood abuse to predict posttraumatic threat symptoms. |
| Q48512439 | The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents |
| Q35738226 | Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research. |
| Q46422551 | Trajectories of cannabis use beginning in adolescence associated with symptoms of posttraumatic stress disorder in the mid-thirties |
| Q27026926 | Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder |
| Q37279826 | Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses |
Search more.